Andrew (Andy) Lee is Senior Vice President and Head, Global Clinical Trial Operations (GCTO) at Merck. In this role, he leads and manages all operations related to the conduct of Merck’s clinical trials, with particular focus on global in-patient clinical trials that are designed and executed to meet cost, speed and quality standards. Andy is also responsible for the design and study and data management of clinical protocols in all regions and countries, as well as the tools, systems and processes used in clinical trial executions.